Stockreport

Immix Biopharma: Thesis Playing Out; Thoughts On Valuation And Competition [Seeking Alpha]

Immix Biopharma, Inc.  (IMMX) 
PDF IMMX's recent $100 million financing removes capital overhang, strengthens negotiating position, and supports a clear path toward BLA submission in mid-2026. With rea [Read more]